Neuropsychiatric features of dementia: What is the big picture?

American Journal of Geriatric Psychiatry

Volumn 14, Issue 7, 2006, Pages 557-560

  Tariot, Pierre N ^a  

^a BANNER ALZHEIMER S INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CHOLINESTERASE INHIBITOR; MEMANTINE; NEUROLEPTIC AGENT; NOOTROPIC AGENT; ZIPRASIDONE;

AGITATION; ALZHEIMER DISEASE; AMNESIA; DEMENTIA; DEPRESSION; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEALTH INSURANCE; HUMAN; PATHOPHYSIOLOGY; PSYCHOSIS;

EID: 33745867633     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.JGP.0000226012.82142.f8     Document Type: Editorial

References (15)

1. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
2. Lyketsos CG, Steinberg M, Tschantz JT, et al: Mental and behavioral disturbances in dementia: findings from the Cache County Study on memory in aging. Am J Psychiatry 2000; 157:708-714
3. Cohen-Mansfield J, Werner P: Longitudinal changes in behavioral problems in old age: a study in an adult day care population. J Gerontol A Biol Sci Med Sci 1998; 53:M65-M71
4. Lee DY, Choo IH, Jhoo JH, et al: Frontal dysfunction underlies depressive syndrome in Alzheimer's disease: A FDG-PET study Am J Geriatr Psychiatry 2006; 14:625-628
5. Mizrahi R, Starkstein S, Jorge R, et al: Phenomenology and clinical correlates of delusions in Alzheimer's disease. Am J Geriatr Psychiatry 2006; 14:573-581
6. Vilalta-Franch J, Garre-Olmo J, Lopez-Pousa S, et al: Comparison of different clinical diagnostic criteria for depression in Alzheimer disease. Am J Geriatr Psychiatry 2006; 14:589-597
7. McKeith IG, Rowan E, Askew K, et al: More severe functional impairment in dementia with Lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. Am J Geriatr Psychiatry 2006; 14:582-588
8. Barak Y, Mazeh D, Plopski I, et al: Intramuscular ziprasidone treatment of acute psychotic agitation in elderly schizophrenia patients. Am J Geriatr Psychiatry 2006; 14:629-633
9. Cummings JL, McRae T, Zhang R, et al: Effects of donepezil on neuropsychiatric symptoms in dementia patients with severe behavioral disorders. Am J Geriatr Psychiatry 2006; 14:605-612
10. Cummings JL: Cholinesterase inhibitors: a new class of psychotropic agents. Am J Psychiatry 2000; 157:4-15
11. Tariot PN, Farlow MR, Grossberg GT, et al: Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 2004; 291:317-324
12. Schneider LS, Dagerman KS, Ingel PS: Efficacy and adverse affects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006; 14:191-210
13. Profenno LA, Tariot PN: Pharmacologic management of agitation in Alzheimer's disease. Dement Geriatr Cogn Disord 2004; 17:65-77
14. Tariot PN, Loy R, Ryan JM, et al: Mood Stabilizers in Alzheimer's Disease: Symptomatic and Neuroprotective Rationales. Berislav Zlokovic (Ed.). Advanced Drug Delivery Reviews 2002; 54:1567-1577.
15. Reiman EM, Caselli RJ, Chen K, et al: Positron emission tomography and magnetic resonance imaging in the study of cognitively normal persons at differential genetic risk of Alzheimer's dementia. In The Living Brain and Alzheimer's. Hyman et al (Eds.), Springer-Verlag Berlin Heidelberg, pp152-177, 2004